Literature DB >> 12476791

Apoptotic cell death in renal injury: the rationale for intervention.

A Ortiz1, P Justo, M P Catalán, A B Sanz, C Lorz, J Egido.   

Abstract

Cell number abnormalities are frequent in renal diseases, and range from the hypercellularity of postinfectious glomerulonephritis to the cell depletion of chronic renal atrophy. Recent research has shown that apoptosis and its regulatory mechanisms contribute to cell number regulation in the kidney. The potential role of apoptosis ranges from induction and progression to repair of renal injury. Death ligands and receptors, such as tumor necrosis factor and Fas ligand, proapoptotic and antiapoptotic Bcl2 family members and caspases have all been shown to participate in apoptosis regulation in the course of renal cell injury. However, the precise role of these proteins is unclear, and the participation of most known apoptosis regulatory proteins has not been studied. We now review the role of apoptosis in renal injury, the potential molecular targets of therapeutic intervention, the therapeutic weapons to modulate the activity of these targets and the few examples of therapeutic intervention on apoptosis, with emphasis on the acute tubular necrosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12476791

Source DB:  PubMed          Journal:  Curr Drug Targets Immune Endocr Metabol Disord        ISSN: 1568-0088


  13 in total

1.  IL-18 mediates proapoptotic signaling in renal tubular cells through a Fas ligand-dependent mechanism.

Authors:  Hongji Zhang; Karen L Hile; Hiroshi Asanuma; Brian Vanderbrink; Ethan I Franke; Matthew T Campbell; Kirstan K Meldrum
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-20

Review 2.  Apoptosis and acute kidney injury.

Authors:  Andrea Havasi; Steven C Borkan
Journal:  Kidney Int       Date:  2011-05-11       Impact factor: 10.612

3.  Inhibition of polycomb repressive complex 2 by targeting EED protects against cisplatin-induced acute kidney injury.

Authors:  Chao Yu; Tingting Li; Jialu Li; Binbin Cui; Na Liu; George Bayliss; Shougang Zhuang
Journal:  J Cell Mol Med       Date:  2022-06-23       Impact factor: 5.295

4.  GSK3beta promotes apoptosis after renal ischemic injury.

Authors:  Zhiyong Wang; Andrea Havasi; Jonathan Gall; Ramon Bonegio; Zhijian Li; Haiping Mao; John H Schwartz; Steven C Borkan
Journal:  J Am Soc Nephrol       Date:  2010-01-21       Impact factor: 10.121

5.  Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury.

Authors:  Péter Hamar; Erwei Song; Gabor Kökény; Allen Chen; Nengtai Ouyang; Judy Lieberman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-04       Impact factor: 11.205

6.  Mitochondrial DNA variants in the pathogenesis of type 2 diabetes - relevance of asian population studies.

Authors:  Pei-Wen Wang; Tsu-Kung Lin; Shao-Wen Weng; Chia-Wei Liou
Journal:  Rev Diabet Stud       Date:  2009-12-30

7.  Necrosis Contributes to the Development of Hypertension in Male, but Not Female, Spontaneously Hypertensive Rats.

Authors:  Mahmoud Abdelbary; Olga Rafikova; Ellen E Gillis; Jacqueline B Musall; Babak Baban; Paul M O'Connor; Michael W Brands; Jennifer C Sullivan
Journal:  Hypertension       Date:  2019-10-28       Impact factor: 10.190

8.  Prevention of acute kidney injury by tauroursodeoxycholic acid in rat and cell culture models.

Authors:  Sandeep Gupta; Shunan Li; Md Joynal Abedin; Kajohnsak Noppakun; Lawrence Wang; Tarundeep Kaur; Behzad Najafian; Cecília M P Rodrigues; Clifford J Steer
Journal:  PLoS One       Date:  2012-11-09       Impact factor: 3.240

9.  The baboon kidney transcriptome: analysis of transcript sequence, splice variants, and abundance.

Authors:  Kimberly D Spradling; Jeremy P Glenn; Roy Garcia; Robert E Shade; Laura A Cox
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

10.  Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia.

Authors:  Ana B Sanz; Maria Dolores Sanchez-Niño; Maria Concepcion Izquierdo; Aniela Jakubowski; Pilar Justo; Luis M Blanco-Colio; Marta Ruiz-Ortega; Jesús Egido; Alberto Ortiz
Journal:  J Cell Mol Med       Date:  2009-05-01       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.